Jack Ragheb

Dr. Ragheb is the Senior Vice President for Translational Sciences and Medicine at NexImmune and the Scientific Founder of JoMoCo Inc. He previously held the role of Senior Medical Fellow for Immunology at Eli Lilly & Co. Before being recruited to Eli Lilly, he was most recently a Chief Medical Research Officer in the Laboratory of Immunology of the Office of Biotechnology Products, CDER, at the U.S. Food Drug Administration and an Attending Physician on the Allergy-Immunology Service, NIAID. A Senior Clinical Investigator in the Laboratory of Immunology, NEI, at the National Institutes of Health, he is a graduate of the Johns Hopkins University and School of Medicine, and is a diplomate of the American Board of Allergy and Immunology. His work and publications have spanned the fields of retrovirology, gene therapy, immune activation, therapeutic protein immunogenicity and clinical trials in immune tolerance.